• Telcon RF Pharmaceutical reported a change in its Abion stake due to a 5-to-1 share consolidation dated Sept. 14, 2026.
• Holdings fell to 3,279,220 common shares from 16,396,104, while the common-share stake stayed at 18.19%.
• Total “specific securities” dropped to 3,410,582 from 17,052,918, with ownership unchanged at 18.78%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abion Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261013000382), on October 13, 2026, and is solely responsible for the information contained therein.